Growth differentiation factor 15 alleviates diastolic dysfunction in mice with experimental diabetic cardiomyopathy
Jordan S. F. Chan(University of Alberta), John R. Ussher(University of Alberta), Erin E. Mulvihill(University of Ottawa), Maria Areli Lorenzana‐Carrillo(University of Alberta), Michael Overduin(University of Birmingham), Kunyan Yang(University of Alberta), Sebastian B. Jørgensen(Novo Nordisk (United States)), Christina T. Saed(University of Alberta), Seyed Amirhossein Tabatabaei Dakhili(University of Alberta), Rakesh Bhat(University of Alberta), Farah Eaton(University of Alberta), Amanda A. Greenwell(University of Alberta), Gregory R. Steinberg(McMaster University Medical Centre), Keshav Gopal(University of Alberta), Indiresh A Mangra-Bala(University of Alberta), Magnus J. Stenlund(University of Alberta), Tanin Shafaati(University of Alberta), Gopinath Sutendra(University of Alberta), Sally R. Ferrari(University of Alberta), Serena M. Pulente(University of Ottawa)
Cited by 14
Related Papers
Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides
|Nature|1992|689
Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
|Endocrine Reviews|2014|602
Knockout of the α2 but Not α1 5′-AMP-activated Protein Kinase Isoform Abolishes 5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranosidebut Not Contraction-induced Glucose Uptake in Skeletal Muscle
|Journal of Biological Chemistry|2004|548
The AMP-activated protein kinase α2 catalytic subunit controls whole-body insulin sensitivity
|Journal of Clinical Investigation|2003|488
Lipogenesis inhibitors: therapeutic opportunities and challenges
|Nature Reviews Drug Discovery|2022|383